IRCT2015102824760N1
Completed
Phase 1
Evaluation of Mesenchymal stem cell therapy effects on the cellular immune response in refractory rheumatoid arthritis patients
Research Chancellor, Mashhad University of Medical Sciences0 sites21 target enrollmentTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Rheumatoid arthritis.
- Sponsor
- Research Chancellor, Mashhad University of Medical Sciences
- Enrollment
- 21
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Resistant RA patients to non\-biological DMARDs
- •Treated RA patients by non\-biological drugs
- •Treated RA patients by Prednisolone, Hydroxychloroquine, Sulfasalazine and Methotrexate
- •Patients aged between 35\-60 years
- •Refractory RA patients with no other rheumatologic disorders and inflammatory diseases
Exclusion Criteria
- •Non\-resistant RA patients to non\-biological DMARDs
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effects of cell therapy with mesenchymal stem cells and platelet-rich plasma in the treatment of knee osteoarthritisOsteoarthritis, KneeRBR-2fr526nniversidade Federal de Mato Grosso do Sul
Recruiting
Phase 1
Evaluation the efficacy of stem cells condition medium on hair transplantation outcomeHair loss.Nonscarring hair loss, unspecifiedL65.9IRCT20200127046282N18Skin and Stem cell Research Center of Tehran University of Medical Sciences30
Active, not recruiting
Phase 1
Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress SyndromeModerate to severe SARS-Cov-2 related acute respiratory distress syndromeMedDRA version: 23.0Level: PTClassification code 10084268Term: COVID-19System Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2020-002772-12-FRCHRU NANCY30
Completed
Not Applicable
Effects of mesenchymal stem cells therapy in peritoneal dialysis patientsChronic kidney disease.Chronic kidney disease, stage 5IRCT2015052415841N2Vice chancellor for research, Tehran University of Medical Sciences10
Terminated
Phase 2
Intra-articular mesenchymal stem cell injections following arthroscopic microfracture versus arthroscopic microfracture alone for knee cartilage defects: a pilot randomised controlled trialACTRN12614000812695Magellan Stem Cells40